Study examines states' Medicaid drug decisions

02/12/2013 | Modern Healthcare (subscription required)

State rules addressing conflicts of interest on panels deciding Medicaid drug formularies vary, a study published in the Journal of the American Medical Association found. Some states are moving to managed care models that include pharmacy benefit managers, which reduce conflicts and their associated costs, a separate commentary says.

View Full Article in:

Modern Healthcare (subscription required)